Occupational Asthma: The Knowledge Needs for a Better Management.
management
professional asthma
surveillance
Journal
Annals of work exposures and health
ISSN: 2398-7316
Titre abrégé: Ann Work Expo Health
Pays: England
ID NLM: 101698454
Informations de publication
Date de publication:
15 03 2022
15 03 2022
Historique:
received:
08
08
2021
revised:
03
11
2021
accepted:
22
11
2021
pubmed:
6
1
2022
medline:
16
4
2022
entrez:
5
1
2022
Statut:
ppublish
Résumé
The management of occupational asthma (OA) may be influenced by several factors and removal from exposure is the main tertiary prevention approach, but it is not always feasible without personal and socioeconomic consequences. Reducing the delay between the onset of suggestive symptoms of OA and the diagnosis of OA is associated with a better prognosis. Workers' education to increase awareness to trigger agents and a medical surveillance program directed especially at at-risk workers could be helpful in reducing this latency time. An early identification of workers who develop rhinitis and conjunctivitis which often precede the onset of asthma symptoms could be important for an early identification of OA. This is particularly important for cases of asthma caused by high-molecular-weight sensitizers and in the early years of employment. The availability of financial support and compensation measures for workers with OA may influence the latency time before diagnosis and, consequently, may influence the OA outcomes. In conclusion, there is a need for high-quality cohort studies that will increase knowledge about risk factor that may influence the timing of diagnosis of OA. This knowledge will be useful for implementation of future surveillance and screening programs in workplaces.
Identifiants
pubmed: 34984434
pii: 6497589
doi: 10.1093/annweh/wxab113
pmc: PMC9006971
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
287-290Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Occupational Hygiene Society.
Références
Eur Respir J. 2012 Mar;39(3):529-45
pubmed: 22379148
N Engl J Med. 2014 Feb 13;370(7):640-9
pubmed: 24521110
Allergy. 2019 Feb;74(2):261-272
pubmed: 29956349
Int J Tuberc Lung Dis. 2020 Jan 1;24(1):8-21
pubmed: 32005302
Eur Respir Rev. 2012 Jun 1;21(124):97-104
pubmed: 22654081
Allergy Asthma Immunol Res. 2019 Mar;11(2):188-200
pubmed: 30661311
J Allergy Clin Immunol Pract. 2020 Nov - Dec;8(10):3264-3275
pubmed: 33161958
Allergy. 2008 Aug;63(8):969-80
pubmed: 18691299
Occup Med (Lond). 2020 Jun 20;70(4):231-234
pubmed: 32307530
J Allergy Clin Immunol. 2013 Mar;131(3):704-10
pubmed: 23058644
Eur Respir Rev. 2012 Jun 1;21(124):88-96
pubmed: 22654080
Curr Allergy Asthma Rep. 2014 May;14(5):431
pubmed: 24633615
Int J Environ Res Public Health. 2020 Jun 24;17(12):
pubmed: 32599814
Cochrane Database Syst Rev. 2019 Oct 08;10:CD006308
pubmed: 31593318
Int J Environ Res Public Health. 2020 Jun 30;17(13):
pubmed: 32627764
Prim Care Respir J. 2007 Oct;16(5):304-10
pubmed: 17934677
Eur Respir J. 2003 Oct;22(4):689-97
pubmed: 14582924
PLoS One. 2016 Jun 09;11(6):e0156141
pubmed: 27280473
Chest. 2008 Sep;134(3 Suppl):1S-41S
pubmed: 18779187
Allergy Asthma Clin Immunol. 2020 Aug 06;16:73
pubmed: 32922457
Eur Respir J. 1994 May;7(5):969-80
pubmed: 8050556
Thorax. 2007 Feb;62(2):147-52
pubmed: 17040933
Chest. 2007 Jun;131(6):1768-75
pubmed: 17505048
Eur Respir J. 2010 Oct;36(4):728-34
pubmed: 20150200
Respir Med. 2015 Mar;109(3):379-88
pubmed: 25657173
Eur Ann Allergy Clin Immunol. 2013 May;45(3):67-73
pubmed: 23862394
J Allergy Clin Immunol. 2016 Feb;137(2):412-6
pubmed: 26220529